hepatitis C
Research roundup
The latest in research news, as gathered by Debbie Rigby Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis This article reviews the pharmacokinetic and pharmacodynamic properties …
Drugs program a success
Hep C program success “extraordinary”, Senate committee hears, but no mention of cost to pharmacy However, there is no mention of the issue of the cost of supplying and stocking …
New Hepatitis C treatment TGA registered
The TGA has registered a new treatment regimen for the treatment of chronic Hepatitis C. MSD announced that Zepatier (elbasvir/grazoprevir) with or without ribavirin has been registered by the TGA …
Hep C medicines: too high a price to pay?
One of the key health-related tasks of the re-elected Coalition government will be to ensure a solution to the supply of the expensive new Hepatitis C medicines. The scale of …
Clinical tips: Hepatitis
Hepatitis C is curable, and all Australians living with the disease should be considered for antiviral therapy, writes Louis Roller Hepatitis is an inflammatory condition of the liver, often characterised …
Large minority not supplying Hep C drugs: poll results
Over a fifth of respondents are not providing the new Hepatitis C treatments to patients, an AJP survey has found. AJP ran a poll to examine to what extent the …
Poll: How are you handling the newly listed Hep C drugs?
When the Turnbull Government decided late last year to PBS list a range of breakthrough Hepatitis C cures, Health Minister Sussan Ley described it as a “watershed moment”. Minister Ley …
Keeping the costs down
Experts say action needed to curb rising PBS costs The cost of the PBS is once again on the rise, according to a new report prepared by the Parliamentary Budget …
Fix hep C supply problems now: Quilty
Pharmacies are facing unprecedented problems supplying new hepatitis C treatments to patients, says Guild executive director David Quilty— and they need to be fixed urgently. In this week’s edition of …
Concern continues over Hep C drug costs
Efforts continue to find a resolution to Hep C payment standoff Government officials have met with pharmacy and industry officials as moves continue to find a solution to the problem …